• Explore /
  • Poster
  • / Switching chemotherapy in adult osteosarcoma patients with poor necrosis rates post neoadjuvant methotrexate, cisplatin, and doxorubicin (MAP).

Switching chemotherapy in adult osteosarcoma patients with poor necrosis rates post neoadjuvant methotrexate, cisplatin, and doxorubicin (MAP).

Abstract Poster

Authors

Grainne M. O'Kane

Grainne O'Kane

Mater Misericordiae University Hospital, Dublin, Ireland

Grainne O'Kane , Karen Anne Cadoo , Elaine Walsh , Conor O'Keane , Gary O'Toole , Sean Dudney , Desmond Carney

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2013 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Sarcoma

Track

Sarcoma

Sub Track

Bone Tumors

Citation

J Clin Oncol 31, 2013 (suppl; abstr 10530)

DOI

10.1200/jco.2013.31.15_suppl.10530

Abstract #

10530

Poster Bd #

42D

Abstract Disclosures

Similar Posters

First Author: Ariel Nash

First Author: Qinglian Tang

First Author: Srikala S. Sridhar

First Author: Maria Grazia Pionelli